Purchase Order 75N91024P00709
Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) awarded a $20,000 firm fixed-price purchase order to Sentieon Inc. on March 20, 2026, to renew an annual software license subscription for one year through March 19, 2027. This contract, which carries no set-aside designation, supports the NCI's genomic research capabilities by providing continued access to Sentieon's proprietary bioinformatics and genomic data analysis software. The work will be performed at the NCI's location in Bethesda, Maryland....
- Sentieon Inc. was awarded a $12,000 firm fixed price purchase order by the National Cancer Institute (NCI), a component of the National Institutes of Health within the Department of Health and Human Services. The proprietary software acquired under this contract will support whole genome sequencing for the Never Smokers Study being conducted by NCI. Sentieon, located in San Jose, California, will serve as the prime contractor to deliver its proprietary software solution from September 1, 2023...
- Sentieon, Inc., a small disadvantaged business specializing in bioinformatics and genomic data analysis software, was awarded a $20,000 firm fixed-price purchase order by the Food and Drug Administration on September 15, 2021. The contract, designated as a Total Small Business set-aside, represents a competitive solicitation posted on June 11, 2021, with a completion date of September 29, 2022. The award supports the FDA's genomic research and analysis initiatives through the delivery of...
- This firm fixed price definitive contract was awarded by the National Institutes of Health National Cancer Institute to Senti Biosciences, Inc., a self-certified small disadvantaged business, for $1,999,993. The contract addresses Topic 414 from the fiscal year 2021 Small Business Innovation Research Program solicitation issued by the Department of Health and Human Services, which sought proposals for synthetic biology gene circuits for cancer therapy. The place of performance is South San...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, to Gene Codes Corporation, a Michigan-based bioinformatics software company. The $11,050 contract is for the renewal of software licenses for Gene Codes' Sequencher product, a critical bioinformatics tool used in genomic research, disease understanding, and other applications across multiple federal...
- This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $97,800.00, is for the procurement of PARTEK software. It does not have a set-aside designation. The award is part of Illumina's broader federal contract and grant portfolio, which includes Indefinite Delivery Vehicles (IDVs) with the...
- This is a $20,009.24 firm fixed-price purchase order service agreement awarded to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract is being awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract has no set-aside designation and the performance location is San Diego, California. Based on Illumina's portfolio of past federal contract awards, this contract will...
- The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...
- This is a federal contract awarded by the National Cancer Institute (NCI), a civilian agency, to Pointcare Genomics Corp, a small minority-owned business, for research and development in biomedical basic research. The contract is a definitive, firm-fixed price contract valued at $299,961.00 and is part of the SBIR (Small Business Innovation Research) Program Phase I. The contract has a total small business set-aside designation and was awarded on September 22, 2015, with a completion date of...